Ecopetrol
EC
Oracle
ORCL
Petroleo Brasileiro SA Petrobras
PBR
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 250.000
- -6.450-2.52%
Close Feb 18 15:59 ET
- 249.010
- -0.990-0.40%
Post 16:05 ET
32.36BMarket Cap-114.68P/E (TTM)
260.000High249.160Low906.29KVolume256.950Open256.450Pre Close227.65MTurnover0.73%Turnover RatioLossP/E (Static)129.46MShares304.39052wk High482.63P/B31.12BFloat Cap141.97552wk Low--Dividend TTM124.46MShs Float304.390Historical High--Div YieldTTM4.23%Amplitude3.650Historical Low251.188Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Alnylam Pharmaceuticals Stock Forum
Alnylam Crushes Earnings with 33% Revenue Growth, Sets Sights on First Profitable Year
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
No comment yet